“…During this period, the activity of several cyclins and cyclin-dependent kinases (CDK), their inhibitors, and transcription factors, both positively and negatively regulating the cell cycle, change [ 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 ]. Significant morphological changes occur in the myocardium, characterized by a decrease in the proliferative activity of CMCs, an increase in their ploidy, size, and differentiation [ 19 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 ]. CMCs go through the last cell cycle without completing cytokinesis, which leads to an increase in the number of binucleated terminally differentiated CMCs at the G 0 [ 28 , 29 , 34 , 35 , 36 , 52 , 53 , 54 ].…”